Congenital afibrinogenemia
MONDO:0008737Familial afibrinogenemia is a coagulation disorder characterized by bleeding symptoms due to a complete absence of circulating fibrinogen.
Also known as: factor I deficiency, afibrinogenemia, afibrinogenemia congenital, afibrinogenemia, congenital, familial afibrinogenemia, hypofibrinogenemia, congenital
15 clinical trials for this condition and its sub-types, 4 tagged with Congenital afibrinogenemia itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Congenital afibrinogenemia
-
Familial hypofibrinogenemia 3 trials
-
Familial hypodysfibrinogenemia 0 trials
-
New clotting drug may cut bleeding risk in rare cancer surgery
Disease control Recruiting nowThis study tests whether a concentrated clotting drug (fibrinogen) can better control major blood loss during surgery for pseudomyxoma peritonei, a rare abdominal cancer. About 90 adults will be randomly assigned to receive either the drug or a standard blood product during their…
Phase 3 • Sponsor: CSL Behring • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Can a 5-Minute blood test save trauma patients from unnecessary treatment?
Knowledge-focused Recruiting nowThis study looks at whether a quick bedside test can measure fibrinogen levels in trauma patients with severe bleeding within minutes, instead of the usual 30-45 minutes. Fibrinogen helps blood clot, and low levels can worsen bleeding. The test is being checked for feasibility an…
Sponsor: Erasmus Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:03 UTC